← Back to Search

Behavioral Intervention

Digital Decision Aid for Sexually Transmitted Infections (STIckER Trial)

N/A
Recruiting
Led By Jason Zucker, MD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
AYA aged 14-24 years
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at completion of all patient visits (within 6 months of enrollment)
Awards & highlights

STIckER Trial Summary

This trial tests an automated tool to help young people get tested for STIs. It aims to reduce STI rates & improve healthcare for young people.

Who is the study for?
This trial is for young individuals aged 14-24 who have been sexually active in the past six months and can speak English. It's not suitable for those with severe illness, cognitive impairments, or non-English speakers.Check my eligibility
What is being tested?
The STIckER study tests a digital decision aid against standard care to see if it increases STI testing among sexually active youth in emergency departments. Forty providers will use either the new tool or provide usual care over six months.See study design
What are the potential side effects?
Since this trial involves a digital decision aid rather than medication, traditional side effects are not applicable. However, there may be indirect effects on patient privacy or stress levels due to increased awareness about STIs.

STIckER Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 14 and 24 years old.

STIckER Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at completion of all patient visits (within 6 months of enrollment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at completion of all patient visits (within 6 months of enrollment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
ED STI Testing Rate
Secondary outcome measures
Acceptability of Intervention Measure (AIM) Score
Extragenital STI testing Rate
Feasibility of Intervention Measure (FIM) Score
+3 more

STIckER Trial Design

2Treatment groups
Experimental Treatment
Group I: STIckERExperimental Treatment1 Intervention
After enrollment but before the start of their clinical visit, participants assigned to a provider in the intervention arm will scan a QR code using their personal mobile phone at the start of their ED visit. If they do not have a mobile phone present, a secure password-protected tablet will be provided by the research staff. This will lead them to go through the STIckER decision aid modules. After completing the modules, participants will show the final outcome to their ED provider which may facilitate an SDM conversation about STI testing. At the end of the visit, the participant will complete the "Patient Intervention Exit Survey" while the provider will complete the "Provider Intervention Exit Survey.
Group II: ControlExperimental Treatment1 Intervention
After enrollment but before the start of their clinical visit, participants assigned to a provider in the control arm will scan a QR code. They will receive a prompt stating, "If you would like to be tested for a sexually transmitted infection today, please tell your medical doctor." At the end of the visit, the participant will complete the "Patient Control Exit Survey" while the provider will complete the "Provider Control Exit Survey". These participants will not receive STIckER training.

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor
1,431 Previous Clinical Trials
2,460,653 Total Patients Enrolled
National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,268 Previous Clinical Trials
5,480,952 Total Patients Enrolled
Jason Zucker, MDPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
100 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the target demographic for this trial primarily geriatric individuals?

"This experiment seeks to enroll individuals between the ages of 14 and 24. Additionally, there are 245 trials for persons under 18 years old and 771 specifically targeting those over 65."

Answered by AI

How many participants are currently enrolled in this experiment?

"Affirmative, the information on clinicaltrials.gov states that this trial is presently searching for participants. The study was originally published on September 1st 2023 and its details were last updated in late August of 2021. A total of 180 individuals are required to be enrolled from two distinct sites."

Answered by AI

Is the opportunity for enrollment in this trial still available?

"According to clinicaltrials.gov, this medical trial is actively seeking participants and has been updated since its original posting on September 1st 2023. Last changes were made August 28th of the same year."

Answered by AI

Is it possible to sign up for this research initiative?

"This medical trial has set a cap of 180 patients who must suffer from an STI and be between the ages of 14-24."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
A Digital Patient Decision Aid to Increase Sexually Transmitted Infection Testing in the Emergency Department: The STIckER Study
Jason E. Zucker 2023. "A Digital Patient Decision Aid to Increase Sexually Transmitted Infection Testing in the Emergency Department: The STIckER Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06014177.
~114 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top